JPMorgan Chase & Co. Increases Position in Quorum Health Corp (QHC)
JPMorgan Chase & Co. boosted its stake in Quorum Health Corp (NYSE:QHC) by 16.3% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 815,934 shares of the company’s stock after buying an additional 114,525 shares during the period. JPMorgan Chase & Co. owned approximately 2.69% of Quorum Health worth $4,006,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds also recently made changes to their positions in QHC. Geode Capital Management LLC grew its stake in Quorum Health by 2.6% in the 1st quarter. Geode Capital Management LLC now owns 213,177 shares of the company’s stock valued at $1,159,000 after buying an additional 5,373 shares during the last quarter. Schwab Charles Investment Management Inc. grew its stake in Quorum Health by 5.5% in the 1st quarter. Schwab Charles Investment Management Inc. now owns 107,695 shares of the company’s stock valued at $586,000 after buying an additional 5,643 shares during the last quarter. KBC Group NV grew its stake in Quorum Health by 35.2% in the 2nd quarter. KBC Group NV now owns 93,531 shares of the company’s stock valued at $388,000 after buying an additional 24,337 shares during the last quarter. Marshall Wace North America L.P. acquired a new position in Quorum Health in the 2nd quarter valued at about $637,000. Finally, Federated Investors Inc. PA acquired a new position in Quorum Health in the 2nd quarter valued at about $157,000. Institutional investors and hedge funds own 81.83% of the company’s stock.
In other Quorum Health news, SVP Shaheed Koury bought 10,000 shares of the firm’s stock in a transaction on Monday, November 13th. The shares were purchased at an average price of $4.69 per share, for a total transaction of $46,900.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Corporate insiders own 4.70% of the company’s stock.
A number of research analysts recently commented on the stock. Royal Bank of Canada reiterated a “hold” rating and issued a $5.00 price target on shares of Quorum Health in a research note on Tuesday, October 3rd. Morgan Stanley upgraded shares of Quorum Health from an “underweight” rating to an “equal weight” rating and set a $3.00 price target on the stock in a research note on Wednesday, December 20th. Finally, Zacks Investment Research lowered shares of Quorum Health from a “buy” rating to a “hold” rating in a research note on Thursday, October 12th. Three equities research analysts have rated the stock with a sell rating and four have given a hold rating to the stock. Quorum Health presently has an average rating of “Hold” and an average target price of $4.13.
Quorum Health Corp (NYSE:QHC) opened at $6.65 on Wednesday. Quorum Health Corp has a 52-week low of $2.54 and a 52-week high of $9.46. The stock has a market cap of $189.05, a P/E ratio of -1.06 and a beta of 7.19. The company has a current ratio of 1.84, a quick ratio of 1.68 and a debt-to-equity ratio of 9.39.
About Quorum Health
Quorum Health Corporation is an operator and manager of general acute care hospitals and outpatient services in the United States. The Company operates in two segments: Hospital operations, which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services, and hospital management advisory and consulting services, which includes Quorum Health Resources, LLC (QHR).
Want to see what other hedge funds are holding QHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quorum Health Corp (NYSE:QHC).
Receive News & Ratings for Quorum Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quorum Health and related companies with Analyst Ratings Network's FREE daily email newsletter.